Intelligence Platform
Patents
Browse 163 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 11246930
Reoviruses having modified sequences
granted patentUS 11213593
Sequence-specific cellular uptake of spherical nucleic acid nanoparticle conjugates
granted patentUS 11192923
Polypeptides including a beta-tricalcium phosphate-binding sequence and uses thereof
granted patentUS 11162945
Methods and compositions for detecting single T cell receptor affinity and sequence
granted patentUS 11155803
Adenosine deaminase base editors and methods of using same to modify a nucleobase in a tar
granted patentUS 11142750
Optimized engineered meganucleases having specificity for a recognition sequence in the He
granted patentUS 11124545
Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vacc
granted patentUS 10982212
Conserved HBV and HCV sequences useful for gene silencing
granted patentUS 10851358
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genom
granted patentUS 10799535
Engineered meganucleases with recognition sequences found in the human T cell receptor alp
granted patentUS 10759833
VMP-like sequences of pathogenic Borrelia species and strains
granted patentUS 10662416
Engineered meganucleases specific for recognition sequences in the hepatitis B virus genom
granted patentUS 10596260
Reoviruses having modified sequences
granted patentUS 10435695
Fusion protein comprising Gaussia luciferase, translation interrupter sequence, and interf
granted patentUS 10323070
VMP-like sequences of pathogenic Borrelia species and strains
granted patentUS 10118961
Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV
granted patentUS 10041053
Rationally-designed single-chain meganucleases with non-palindromic recognition sequences
granted patentUS 10039827
Reoviruses having modified sequences
granted patentUS 9993545
Foot and mouth disease virus (FMDV) consensus proteins, coding sequences therefor and vacc
granted patentUS 9982263
Conserved HBV and HCV sequences useful for gene silencing
granted patentUS 9937196
Genomic sequence of avian paramyxovirus type 2 and uses thereof
granted patentUS 9670254
VMP-like sequences of pathogenic Borrelia species and strains
granted patentUS 9605255
Oligonucleotides for making a change in the sequence of a target RNA molecule present in a
granted patentUS 9518096
Virus-like particles comprising composite capsid amino acid sequences for enhanced cross r
granted